AZN vs DNTH · P/E 28, $288.38B cap vs rev $6.2M
AstraZeneca PLC (AZN) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the AZN and DNTH stock pages for the full models.
Not investment advice.